Mar 01, 2016 7:00am EST NeoGenomics Reports Record Revenue of $27.2 Million and Record Adjusted EBITDA of $2.9 Million in Fourth Quarter, Driven by Strong Volume Gains
Jan 26, 2016 7:00am EST NeoGenomics Schedules its Q4 2015 and Full Year 2015 Earnings Release for March 1, 2016
Dec 08, 2015 7:00am EST NeoGenomics Launches New Liquid Biopsy Tests for Monitoring Solid Tumors and Predicting Resistance to BTK Inhibitors
